Literature DB >> 27660002

Increased Act1/IL-17R expression in Hirschsprung's disease.

Christian Tomuschat1, Anne Marie O'Donnell1, David Coyle1, Prem Puri2,3.   

Abstract

PURPOSE: Hirschsprung's disease -associated enterocolitis (HAEC) is the most common cause of morbidity and mortality in Hirschsprung's disease (HSCR). Altered intestinal epithelial barrier function is implicated in the pathogenesis of HAEC. IL-17 is a proinflammatory cytokine that plays a crucial role in host defense against microbial organisms in the development of inflammatory diseases. Act1 is an essential adaptor molecule required for the IL-17-mediated inflammatory responses via interaction with IL-17 receptor (IL-17R). We designed this study to investigate the hypothesis that Act1/Il-17R expression is upregulated in HSCR.
METHODS: We investigated Act1 and IL17R expression in ganglionic andaganglionic bowel of HD patients (n = 10) and controls (n = 10). qPCR, Western blotting and confocal immunofluorescence were performed. MAIN
RESULTS: qPCR and Western blot analysis revealed that Act1 and IL17R are strongly expressed in the aganglionic and ganglionic colon of patients with HSCR. Act1 and IL17R expression was significantly increased in HSCR specimens compared to controls (p < 0.05). Confocal microscopy revealed a markedly increased expression of Act1 and IL17R in the colonic epithelium of patients with HSCR compared to controls.
CONCLUSION: To our knowledge, we report, for the first time, the expression of Act1 in the human colon. The increased expression of Act1 and Il-17 in the aganglionic and ganglionic bowel in HSCR may result in IL-17-mediated increased inflammatory response leading to the development of HAEC.

Entities:  

Keywords:  Act1; Hirschsprung’s disease; Hirschsprung’s-associated enterocolitis (HAEC); IL17R; Inflammatory bowel disease

Mesh:

Substances:

Year:  2016        PMID: 27660002     DOI: 10.1007/s00383-016-3980-4

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   1.827


  23 in total

Review 1.  The enteric nervous system as a regulator of intestinal epithelial barrier function in health and disease.

Authors:  Susanne A Snoek; Marleen I Verstege; Guy E Boeckxstaens; René M van den Wijngaard; Wouter J de Jonge
Journal:  Expert Rev Gastroenterol Hepatol       Date:  2010-10       Impact factor: 3.869

2.  The IL-23/IL-17 axis in inflammation.

Authors:  Yoichiro Iwakura; Harumichi Ishigame
Journal:  J Clin Invest       Date:  2006-05       Impact factor: 14.808

Review 3.  IL-17 family: cytokines, receptors and signaling.

Authors:  Chunfang Gu; Ling Wu; Xiaoxia Li
Journal:  Cytokine       Date:  2013-09-03       Impact factor: 3.861

4.  Characterization of the intestinal microbiome of Hirschsprung's disease with and without enterocolitis.

Authors:  Zhilong Yan; Valeriy Poroyko; Song Gu; Zheng Zhang; Liya Pan; Jing Wang; Nan Bao; Li Hong
Journal:  Biochem Biophys Res Commun       Date:  2014-02-10       Impact factor: 3.575

5.  A population-based, complete follow-up of 146 consecutive patients after transanal mucosectomy for Hirschsprung disease.

Authors:  Malla I Neuvonen; Kristiina Kyrklund; Harry G Lindahl; Antti I Koivusalo; Risto J Rintala; Mikko P Pakarinen
Journal:  J Pediatr Surg       Date:  2015-02-14       Impact factor: 2.545

Review 6.  Hirschsprung's disease: a search for etiology.

Authors:  P Puri; K Ohshiro; T Wester
Journal:  Semin Pediatr Surg       Date:  1998-08       Impact factor: 2.754

7.  Intestinal neuroendocrine cells and goblet cells are mediators of IL-17A-amplified epithelial IL-17C production in human inflammatory bowel disease.

Authors:  M Friedrich; J Diegelmann; J Schauber; C J Auernhammer; S Brand
Journal:  Mucosal Immunol       Date:  2014-12-10       Impact factor: 7.313

8.  Growth Factor FGF2 Cooperates with Interleukin-17 to Repair Intestinal Epithelial Damage.

Authors:  Xinyang Song; Dai Dai; Xiao He; Shu Zhu; Yikun Yao; Hanchao Gao; Jingjing Wang; Fangfang Qu; Ju Qiu; Honglin Wang; Xiaoxia Li; Nan Shen; Youcun Qian
Journal:  Immunity       Date:  2015-08-25       Impact factor: 31.745

9.  Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members.

Authors:  Matthew J Ruddy; Grace C Wong; Xikui K Liu; Hiroyasu Yamamoto; Soji Kasayama; Keith L Kirkwood; Sarah L Gaffen
Journal:  J Biol Chem       Date:  2003-11-04       Impact factor: 5.157

10.  Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.

Authors:  P D Cani; S Possemiers; T Van de Wiele; Y Guiot; A Everard; O Rottier; L Geurts; D Naslain; A Neyrinck; D M Lambert; G G Muccioli; N M Delzenne
Journal:  Gut       Date:  2009-02-24       Impact factor: 23.059

View more
  2 in total

1.  Altered expression of IL36γ and IL36 receptor (IL1RL2) in the colon of patients with Hirschsprung's disease.

Authors:  Christian Tomuschat; Anne Marie O'Donnell; David Coyle; Prem Puri
Journal:  Pediatr Surg Int       Date:  2016-11-16       Impact factor: 1.827

2.  Correlation analysis of IL-11 polymorphisms and Hirschsprung disease subtype susceptibility in Southern Chinese Children.

Authors:  Hong Zhang; Jing-Lu Zhao; Yi Zheng; Xiao-Li Xie; Li-Hua Huang; Le Li; Yun Zhu; Li-Feng Lu; Tu-Qun Hu; Wei Zhong; Qiu-Ming He
Journal:  BMC Med Genomics       Date:  2021-01-19       Impact factor: 3.063

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.